Analyst initiated coverage on Lumexa Imaging Holdings with a new price target
$LMRI
Medical Specialities
Health Care
Analyst initiated coverage of Lumexa Imaging Holdings with a rating of Overweight and set a new price target of $23.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/9/2026 | $23.00 | Outperform → Strong Buy | Raymond James |
| 1/5/2026 | $23.00 | Overweight | Analyst |
| 1/5/2026 | $23.00 | Buy | Jefferies |
| 1/5/2026 | $22.00 | Overweight | Wells Fargo |
| 1/5/2026 | Outperform | William Blair | |
| 1/5/2026 | $23.00 | Outperform | Raymond James |
| 1/5/2026 | $23.00 | Outperform | Leerink Partners |
| 1/5/2026 | $22.00 | Buy | Deutsche Bank |
DEFA14A - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)
DEF 14A - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)
8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)
4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)
4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)
3 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)
Raymond James upgraded Lumexa Imaging Holdings from Outperform to Strong Buy and set a new price target of $23.00
Analyst initiated coverage of Lumexa Imaging Holdings with a rating of Overweight and set a new price target of $23.00
Jefferies initiated coverage of Lumexa Imaging Holdings with a rating of Buy and set a new price target of $23.00
RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its first quarter 2026 financial and operational results after market close on Tuesday, May 12, 2026. The Company will host a conference call and live webcast to discuss the results at 5:00 p.m. ET. The live audio webcast will be available in the Investor Relations section of the Company's website at ir.lumexaimaging.com. A replay of the webcast will be available for approximately one year. About Lumexa Imaging Lumexa Imaging is a nationwide provider of outpatient medical imaging. With over 5,000 team member
RALEIGH, N.C., April 20, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced the appointment of Kyle Lynch as its new Chief Growth Officer (CGO). Lynch joins the executive leadership team to lead the company's enterprise growth strategy, with responsibility for expanding Lumexa Imaging's platform through joint ventures, acquisitions, and de novo development. In this role, Lynch will oversee the full growth lifecycle, including opportunity origination, transaction execution, and post-close value realization, with a focus on driving sustainable, profitable growth and maximizing return on invested capita
RALEIGH, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced certain financial results for the fourth quarter ended December 31, 2025, and reiterated full year 2026 guidance. The financial results included in this release pertaining to the fourth quarter and full year 2025 are preliminary, unaudited, and subject to final review and adjustment. "The fourth quarter of 2025 marked a strong close to an important year for Lumexa Imaging, with continued momentum across the business," said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. "Strong Adjusted EBITDA growth was driven by a
RALEIGH, N.C., April 20, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced the appointment of Kyle Lynch as its new Chief Growth Officer (CGO). Lynch joins the executive leadership team to lead the company's enterprise growth strategy, with responsibility for expanding Lumexa Imaging's platform through joint ventures, acquisitions, and de novo development. In this role, Lynch will oversee the full growth lifecycle, including opportunity origination, transaction execution, and post-close value realization, with a focus on driving sustainable, profitable growth and maximizing return on invested capita
The Middleby Corporation (NASDAQ:MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition of Mr. Eisenberg, the Middleby Board expands to twelve members. "We are pleased to welcome Glenn Eisenberg to the Middleby Board. His deep experience will be an immediate asset as we execute our strategic transformation," said Tim FitzGerald, Middleby CEO. "Glenn has a proven 20-year track record of success as a public company CFO and senior operating executive across complex global manufacturing businesses. His expertise in financial discipline, industrial manufacturing, capital allocation,
RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its first quarter 2026 financial and operational results after market close on Tuesday, May 12, 2026. The Company will host a conference call and live webcast to discuss the results at 5:00 p.m. ET. The live audio webcast will be available in the Investor Relations section of the Company's website at ir.lumexaimaging.com. A replay of the webcast will be available for approximately one year. About Lumexa Imaging Lumexa Imaging is a nationwide provider of outpatient medical imaging. With over 5,000 team member